Around the Market rssfeed

Small Cap Movers (JAZZ, BKS, MNKD, SPRD)

Posted on January 16, 2012 by Simon Bell

Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ) climbed 9.41% to $45.36 in the morning hour after the company provided full year financial guidance for 2012 reflecting the planned business combination with Azur Pharma Public Limited Company, which the companies are targeting to … Continue reading →

Written by: Simon Bell on January 16, 2012.
Posted in Around the Market, Contributors | Tagged , , , | Leave a comment

Hot Stocks (LVS, YOKU, Apple Inc, Citigroup Inc, SINA)

Posted on January 16, 2012 by Rohit Sarin

Las Vegas Sands Corp (NYSE:LVS) is up 4.81% to $45.79. The 52-week range for the stock is $33.85 and $55.47. The Company has Price/Sales ratio of 3.80 and Price/Book ratio of 4.39. The 50-Day Moving Average and 200-Day Moving Average … Continue reading →

Written by: Rohit Sarin on January 16, 2012.
Posted in Around the Market, Contributors | Tagged , , , , , , , , , , | Leave a comment

KIT digital Gains After Year-End Update

Posted on January 12, 2012 by Richard Carlyle

KIT digital, Inc. (NASDAQ: KITD) climbed 6.41% to $8.96 in the morning hour after the company provided an update on its 2011 performance, closed the asset purchase of Sezmi Corporation, raised its 2012 guidance, and implemented plans to move its … Continue reading →

Written by: Richard Carlyle on January 12, 2012.
Posted in Around the Market, Contributors | Tagged , , | Leave a comment

Global Payments Announces 1Q Results

Posted on January 11, 2012 by ankit

Global Payments Inc. (NYSE: GPN) declined 2.54% to $46.79 in the early hour after the company announced results for its fiscal second quarter ended November 30, 2011. The company reported a second quarter profit of $61.2 million, or $0.78 a … Continue reading →

Written by: ankit on January 11, 2012.
Posted in Around the Market, Contributors | Tagged , | Leave a comment

Robbins & Myers Declares 1Q Results

Posted on January 10, 2012 by Richard Carlyle

Robbins & Myers, Inc. (NYSE: RBN) declined 0.38% to $49.88 in the morning hour after the company announced first-quarter results.   The company reported a first quarter profit of $35.3 million, or $0.77 a share, up from $14.7 million, or … Continue reading →

Written by: Richard Carlyle on January 10, 2012.
Posted in Around the Market, Contributors | Tagged , , | Leave a comment

Small Cap Movers (GSM, PLCE, SODA, RAD)

Posted on January 9, 2012 by Rohit Sarin

Globe Specialty Metals, Inc. (NASDAQ: GSM) plunged 11.16% to $12.30 in the early hour. The 52 week trading range for the company is $12.26 – $25.67. The company has declined over 29% in the last one year. Globe Specialty Metals … Continue reading →

Written by: Rohit Sarin on January 9, 2012.
Posted in Around the Market, Contributors | Tagged , , , | Leave a comment

Mid Cap Movers (STX, LSI, MRVL, TSO)

Posted on January 8, 2012 by ankit

Seagate Technology PLC (NASDAQ: STX) increased 5.71% to $17.77 in the early hour. The company expects to generate second quarter revenue between $3.1 billion and $3.2 billion, exceeding analysts’ consensus forecast of $2.8 billion. The company will formally release quarterly … Continue reading →

Written by: ankit on January 8, 2012.
Posted in Around the Market, Contributors | Tagged , , , | Leave a comment

Dillard’s, Inc. (DDS) Slumped After Third Quarter Earnings

Posted on January 6, 2012 by Richard Carlyle

Shares of Dillard’s, Inc.  (NYSE:DDS) slumped on Friday following the company reported lower than estimated gross margin for its retail business, overshadowing its sharp increase in net profit during the this quarter. The company said that it net profit during … Continue reading →

Written by: Richard Carlyle on January 6, 2012.
Posted in Around the Market, Contributors | Tagged , , , , | Leave a comment

Top Biotech Movers (CTIC, CXM, ITMN, GNOM, GEVA)

Posted on January 5, 2012 by Richard Carlyle

Cell Therapeutics, Inc. (NASDAQ: CTIC) declined 3.57% to $1.08 in the morning hours after the company announced that on February 9, 2012 the U.S. Food and Drug Administration’s (FDA) Oncologic Drugs Advisory Committee (ODAC) will review CTI’s resubmitted New Drug … Continue reading →

Written by: Richard Carlyle on January 5, 2012.
Posted in Around the Market, Contributors | Tagged , , , , | Leave a comment

Big Gainers & Losers (DNDN, ACOM, NEI, BKS, AEO)

Posted on January 4, 2012 by Rohit Sarin

Dendreon Corporation (NASDAQ: DNDN) surged 39.08% to $10.57 in the morning hours after the company said that fourth quarter gross product revenue was approximately $82 million. Full-year gross revenues from PROVENGE sales were approximately $228 million. Ancestry.com Inc (NASDAQ: ACOM) … Continue reading →

Written by: Rohit Sarin on January 4, 2012.
Posted in Around the Market, Contributors | Tagged , , , , | Leave a comment